Background

A retrospective review of clinical manifestations and demographic pattern of patients diagnosed as chronic granulomatous disease (CGD) from 7 hospitals in Malaysia. An analysis of the available database would establish clinical characteristics, diagnoses and outcome including microbiologic pattern. Studying the demography allows us to document the occurrence of CGD amongst multiethnic groups and its geographical distribution for Malaysia.

Methods

Data from the Malaysia Primary Immunodeficiency Network (MyPIN) with cases of CGD diagnosed from 1991 until 2016 were collated and analysed.

Results

Twenty patients were diagnosed as CGD. Males (N = 13, 65%) outnumber females (N = 7, 35%). CGD is commonest amongst the Malays (65%) followed by the Chinese (15.0%), Indians (10.0%) and natives of Borneo (10.0%), reflecting the ethnic composition of the country. The mean age of diagnosis was 3.7 years. There was a positive family history in 40% of the cases. Abscess was the main presenting feature in 16 patients (80%) with one involving the brain. Pneumonia occurred in 10 (50%) and one with complicated bronchiectasis. Catalase-positive bacteria were the most commonly isolated pathogen with Chromobacterium violaceum predominating (N = 5, 25%) with consequent high mortality (N = 4, 80%). All CGD patients with C. violaceum infection displayed CD4 + (T helper cells) lymphopenia.

Conclusion

This study has shown CGD occurs in the major ethnic groups of Malaysia. To the best of our knowledge, this is the first and the largest series of chronic granulomatous disease in South East Asia which may be reflective of similar clinical pattern in the region. C. violaceum infection is associated with a higher mortality in CGD patients in Malaysia. All the CGD patients with C. violaceum infection in this patient series displayed CD4 + (T helper) lymphopenia. We recorded rare clinical manifestation of CGD viz. brain abscess and bronchiectasis.

1. Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40:24–64.
2. Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–169.
3. Abd Hamid IJ, Azman NA, Gennery AR, Mangantig E, Hashim IF, Zainudeen ZT. Systematic review of primary immunodeficiency diseases in Malaysia: 1979–2020. Front Immunol. 2020;11:1923. https://doi.org/10.3389/fimmu.2020.01923.
4. Noh LM, Noah RM, Wu LL, Nasuruddin BA, Junaidah E, Ooi CP, et al. Chronic granulomatous disease—a report in two Malay families. Singapore Med J. 1994;35:505–508.
5. Noh LM, Nasuruddin BA, Abdul Latiff AH, Noah RM, KamarulAzahar MR, Norzila MZ, et al. Clinical-epidemiological pattern of primary immunodeficiencies in Malaysia 1987–2006: a 20-year experience in four Malaysian hospitals. Med J Malaysia. 2013;68:13–17.
6. Lim DL, Thong BY, Ho SY, Shek LPC, Lou J, Leong KP, et al. Primary immunodeficiency diseases in Singapore—the last 11 years. Singapore Med J. 2003;44(11):579–586.
7. Benjasupattananan B, Simasathein T, Vichyanond P, Leungwedchakarn V, Visitsunthorn N, Pacharn P, et al. Clinical characteristics and outcome of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. J Clin Immunol. 2009;29:357–364.
8. Fernando SJA, Faiz NM, Handunneti SM, De Silva AD, Dasanayake WMDK, Wickramasinghe GD, et al. Preliminary study on CGD in Sri Lanka. Allergy Asthma Clin Immunol. 2018;17:14–37.
9. Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol. 2014;34:58–67.
10. Roos D, Kuijpers TW, Curnutte JT. Chronic granulomatous disease. In: Ochs HD, Edvard-Smith CI, Puck JM, editors. Primary immunodeficiency diseases: a molecular and genetic approach. New York: Oxford University Press; 2007. p. 534–540.
11. Zainudeen ZT, Hashim IF, Abd Hamid IJ. Chronic granulomatous disease. Malays J Paediatr Child Health. 2020;25:28–29.
12. Noah RM, Jais MR, Noh LM. Evaluation of variable parameters in neutrophil function test using chemiluminescence assay. Malays J Pathol. 1994;16:157–160.
13. Ismail IH, Jamli FM, Othman IS, Noh LM, Abdul Latiff AH. Malaysia’s first transplanted case of chronic granulomatous disease: the journey of overcoming obstacles. Children (Basel). 2016;17(3):9. https://doi.org/10.3390/children3020009.
14. Salaria M, Singh S, Kumar L, Datta U, Sehgal S. Chronic granulomatous disease. Indian Pediatr. 1999;36:594–596.
15. Ma JS, Chen PY, Fu LS, Chi CS, Huang YF, Lin CY, et al. Chronic granulomatous disease: a case report. J Microbiol Immunol Infect. 2000;33:118–122.
16. Gill HK, Kumar HC, Dhaliwal JS, Zabidi F, Sendut IH, Noah RM, et al. Defining p47-phox deficient chronic granulomatous disease in a Malay family. Asian Pac J Allergy Immunol. 2012;30:313–320.
17. Wu J, Wang WF, Zhang Y, Chen T. Clinical features and genetic analysis of 48 patients with chronic granulomatous disease in a single center study from Shanghai, China (2005–2015). J Immunol Res. 2017. https://doi.org/10.1155/2017/8745254.
18. van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: the European experience. PLoS ONE. 2009;4:e5234. https://doi.org/10.1371/journal.pone.0005234.
19. Bortoletto P, Lyman K, Camacho A, et al. Chronic granulomatous disease: a large, single-center US experience. Pediatr Infect Dis J. 2015;34:1110–1114.
20. Magnani A, Brosselin P, Beauté J, et al. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. 2014;134:655–662.
21. Movahedi M, Aghamohammadi A, Rezaei N, et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int Arch Allergy Immunol. 2004;134:253–259.
22. Köker MY, Camcioglu Y, van Leeuwen K, et al. Clinical, functional and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. 2013;132:1156–1163.
23. Wolach B, Gavrieli R, de Boer M, et al. Chronic granulomatous disease: the Israeli experience with 84 patients. Am J Hematol. 2017;92:28–36.
24. Suliaman F, Amra N, Sheikh S, et al. Epidemiology of chronic granulomatous disease of childhood in Eastern Province, Saudi Arabia. Pediatr Asthma Allergy Immunol. 2009;22:21–26.
25. Martire B, Rondelli R, Soresina A, et al. Clinical features, long-term follow-up, and outcome of a large cohort of patients with chronic granulomatous disease. Clin Immunol. 2008;126:155–164.
26. Sureisen M, Choon SK, Tai CC. Recurrent Chromobacterium violaceum infection in a patient with chronic granulomatous disease. Med J Malaysia. 2008;63:346–347.
27. Frawley AA, Powell L, McQuiston JR, et al. Necrotizing pneumonia caused by Chromobacterium violaceum. Am J Trop Med Hyg. 2018;9:164–167.
28. Lee PP, Lau YL. Endemic infections in Southeast Asia provide new insights to the phenotypic spectrum of primary immunodeficiency disorders. Asia Pac J Allergy Immunol. 2013;31:217–226.
29. Bansie R, Harkisoen S, Lachman V, et al. Rare infection in the tropics that is not uncommon in cases of chronic granulomatous disease. Access Microbiol. 2019;18:39. https://doi.org/10.1099/acmi.0.000039.
30. Sirinavin S, Techasaensiri C, Benjaponpitak S, et al. Invasive Chromobacterium violaceum infection in children: case report and review. Pediatr Infect Dis J. 2005;24:559–561.
31. Meher-Homji Z, Mangalore RP, Johnson PDR, Chua KYL. Chromobacterium violaceum infection in chronic granulomatous disease. JMM Case Rep. 2017;4:e005084. https://doi.org/10.1099/jmmcr.0.005084.
32. Bustamante J, Aksu G, Vogt G, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol. 2007;120:32–38.
33. Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27:89–99.
34. Janeway CA, Craig J, Davidson M, et al. Hypergammaglobulinemia associated with severe recurrent infection. Am J Dis Child. 1954;88:388–392.
35. Leiding JW, Holland SM. Chronic granulomatous disease. In: Sullivan KE, Stiehm ER, editors. Stiehm’s immune deficiency. Elsevier; 2014. p. 633–648.
36. Thomsen IP, Smith MA, Holland SM, Creech CB. A comprehensive approach to management of chronic granulomatous disease. J Allergy Clin Immunol Pract. 2016;4:1082–1088.
37. Chiesa R, Wang J, Blok H, et al. Hematopoietic cell transplantation in chronic granulomatous disease. Blood. 2020;136:1201–1211.
38. Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med. 2010;363:2600–2610.